SCHEMBL9116501

SCHEMBL9116501

NS(=O)(=O)c1ccc(C2=CC3(C=C2c2ccc(Cl)cc2)CCC3)nc1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 11/20 0.43
PTGS1 P23219 6/20 0.43
CA2 P00918 5/20 0.41
CA1 P00915 4/20 0.41
CA4 P22748 4/20 0.41
CA5A P35218 2/20 0.41
CA9 Q16790 2/20 0.41
CA5B Q9Y2D0 2/20 0.41
CA7 P43166 3/20 0.40
CA12 O43570 1/20 0.40
CA3 P07451 1/20 0.40
CA6 P23280 1/20 0.40
CA13 Q8N1Q1 1/20 0.40
CA14 Q9ULX7 1/20 0.40
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
IKBKB O14920 1/20 0.37
ALOX5AP P20292 1/20 0.36
MLNR O43193 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9117988 0.98 PTGS2 (0.43) PTGS2PTGS1CA2CA1CA4
SCHEMBL9119641 0.95 PTGS2 (0.45) PTGS2PTGS1CA2CA1CA4
SCHEMBL9118587 0.93 PTGS2 (0.43) PTGS2PTGS1CA2CA1CA4
SCHEMBL9117683 0.91 PTGS2 (0.43) PTGS2PTGS1CA2CA1CA4
SCHEMBL9117334 0.88 PTGS2 (0.52) PTGS2PTGS1CA2CA1CA4
SCHEMBL9116432 0.88 PTGS2 (0.43) PTGS2PTGS1CA2CA1CA4
SCHEMBL9118717 0.88 PTGS2 (0.49) PTGS2PTGS1ALOX5AP
SCHEMBL9117918 0.88 PTGS2 (0.45) PTGS2PTGS1CA2CA1CA4
SCHEMBL9119256 0.88 CA2 (0.40) PTGS2PTGS1CA2CA1CA4
SCHEMBL9118428 0.86 PTGS2 (0.52) PTGS2PTGS1CA2CA1CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1995030652-A1 SUBSTITUTED SPIRODIENES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1995-11-16 WO claimed
WO-1995030652-A1 SUBSTITUTED SPIRODIENES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1995-11-16 WO disclosed